Regeneron loses bid to scrap infringement lawsuit linked to COVID antibody cocktail
Regeneron loses bid to scrap infringement lawsuit linked to COVID [...]
Regeneron loses bid to scrap infringement lawsuit linked to COVID [...]
Novartis sells pair of manufacturing plants as Sandoz strategic review [...]
FDA says no, thank you to Xpovio’s cancer expansion bid, [...]
A year later at the SOTU, deja vu all over [...]
Eli Lilly’s Medicaid rebate payments under fire as whistleblower lawsuit [...]
A DOE-Based Approach to Optimizing T-Cell Expansion ncavazza Tue, 03/01/2022 [...]
FibroGen’s roxadustat safety mess draws SEC scrutiny as AstraZeneca-partnered anemia [...]
COPD Foundation links arms with Ena on antiviral nasal spray [...]
Trevi revs up extended-release opioid cough program, exiting phase 2 [...]
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial [...]